PML-RARα promoter occupancy
Gene ID . | Symbol . | Description . | PML binding . | PML binding primary patient leukemia cells—PCR . | RARE position . | |
---|---|---|---|---|---|---|
U937chip . | U937PCR . | |||||
NM 013258 | PYCARD | PYD and CARD domain–containing, transcript variant 1 | 1.63 | 16.45 | ND | 971-976 (−) |
NM 000389 | p21CIP1/CDKN1A | Cyclin-dependent kinase inhibitor 1A | 1.67 | 13.09 | 5.86 | 271-276 (−); 1194–1212 (−) |
NM 006866 | LILRA2 | Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A, member 2 | 3.13 | 12.19 | ND | — |
NM 181868 | APAF1 | Apoptotic protease–activating factor isoform d | 1.36 | 7.52 | 3.05 | — |
NM 022047 | DEF6 | Differentially expressed in FDCP 6 homolog | 4.32 | 7.01 | 3.82 | 107-112 (−) |
NM 002159 | HTN1 | Histatin 1 | 2.83 | 6.59 | 3.97 | 798-803 (−) |
NM 007067 | MYST2 | MYST histone acetyltransferase 2 | 1.51 | 6.28 | 2.60 | — |
NM 001005291 | SREBF1 | Sterol regulatory element binding transcription | 1.50 | 4.41 | 5.58 | 380-385 (−) |
NM 147166 | AKAP9 | A-kinase anchor protein 9 isoform 4 | 2.26 | 4.00 | 0.11 | 694-699 (−) |
NM 001782 | CD72 | CD72 antigen | 1.66 | 3.71 | 0.78 | — |
NM 005980 | S100P | S100 calcium-binding protein P | 1.57 | 3.51 | 6.41 | 697-702 (+) |
NM 032883 | C20orf100 | Chromosome 20 open reading frame 100 | 1.46 | 3.48 | 1.31 | — |
NM 020349 | ANKRD2 | Homo sapiens ankyrin repeat domain 2 | 1.98 | 3.45 | ND | — |
NM 002923 | RGS2 | Homo sapiens regulator of G-protein signaling 2 | 1.34 | 3.32 | ND | — |
NM 000917 | P4HA1 | Proline 4-hydroxylase, alpha polypeptide I | 1.40 | 2.53 | 6.11 | — |
NM 199077 | CNNM2 | Homo sapiens cyclin M2 | 1.84 | 2.49 | ND | 464-469 (−) |
NM 000523 | HOXD13 | Homeobox D13 | 1.77 | 2.33 | 2.30 | 628-633 (−) |
NM 177435 | PPARD | Peroxisome proliferative activated receptor, delta | 1.92 | 1.95 | 2.62 | 806-811 (+) |
NM 003707 | RUVBL1 | RuvB-like 1 (E coli) | 1.52 | 1.95 | 1.88 | 589-594 (+) |
NM 020898 | CALCOCO1 | Homo sapiens calcium-binding and coiled-coil domain 1 | 1.68 | 1.54 | 1.21 | — |
Gene ID . | Symbol . | Description . | PML binding . | PML binding primary patient leukemia cells—PCR . | RARE position . | |
---|---|---|---|---|---|---|
U937chip . | U937PCR . | |||||
NM 013258 | PYCARD | PYD and CARD domain–containing, transcript variant 1 | 1.63 | 16.45 | ND | 971-976 (−) |
NM 000389 | p21CIP1/CDKN1A | Cyclin-dependent kinase inhibitor 1A | 1.67 | 13.09 | 5.86 | 271-276 (−); 1194–1212 (−) |
NM 006866 | LILRA2 | Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A, member 2 | 3.13 | 12.19 | ND | — |
NM 181868 | APAF1 | Apoptotic protease–activating factor isoform d | 1.36 | 7.52 | 3.05 | — |
NM 022047 | DEF6 | Differentially expressed in FDCP 6 homolog | 4.32 | 7.01 | 3.82 | 107-112 (−) |
NM 002159 | HTN1 | Histatin 1 | 2.83 | 6.59 | 3.97 | 798-803 (−) |
NM 007067 | MYST2 | MYST histone acetyltransferase 2 | 1.51 | 6.28 | 2.60 | — |
NM 001005291 | SREBF1 | Sterol regulatory element binding transcription | 1.50 | 4.41 | 5.58 | 380-385 (−) |
NM 147166 | AKAP9 | A-kinase anchor protein 9 isoform 4 | 2.26 | 4.00 | 0.11 | 694-699 (−) |
NM 001782 | CD72 | CD72 antigen | 1.66 | 3.71 | 0.78 | — |
NM 005980 | S100P | S100 calcium-binding protein P | 1.57 | 3.51 | 6.41 | 697-702 (+) |
NM 032883 | C20orf100 | Chromosome 20 open reading frame 100 | 1.46 | 3.48 | 1.31 | — |
NM 020349 | ANKRD2 | Homo sapiens ankyrin repeat domain 2 | 1.98 | 3.45 | ND | — |
NM 002923 | RGS2 | Homo sapiens regulator of G-protein signaling 2 | 1.34 | 3.32 | ND | — |
NM 000917 | P4HA1 | Proline 4-hydroxylase, alpha polypeptide I | 1.40 | 2.53 | 6.11 | — |
NM 199077 | CNNM2 | Homo sapiens cyclin M2 | 1.84 | 2.49 | ND | 464-469 (−) |
NM 000523 | HOXD13 | Homeobox D13 | 1.77 | 2.33 | 2.30 | 628-633 (−) |
NM 177435 | PPARD | Peroxisome proliferative activated receptor, delta | 1.92 | 1.95 | 2.62 | 806-811 (+) |
NM 003707 | RUVBL1 | RuvB-like 1 (E coli) | 1.52 | 1.95 | 1.88 | 589-594 (+) |
NM 020898 | CALCOCO1 | Homo sapiens calcium-binding and coiled-coil domain 1 | 1.68 | 1.54 | 1.21 | — |
ND indicates not determined; and —, none.